Hyperion Defi, INC. (HYPD) — SEC Filings

Overview

Hyperion Defi, INC. (HYPD) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Mar 26, 2026: HYPERION DEFI, INC. filed an 8-K on March 26, 2026, reporting on Items 2.02 (Results of Operations and Financial Condition), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), and 7.01 (Regulation FD Disclosure). This indicates the company is likely releasing financial

Sentiment Summary

Across 50 filings, the sentiment breakdown is: 2 bullish, 4 bearish, 42 neutral, 2 mixed. The dominant filing sentiment for Hyperion Defi, INC. is neutral.

Filing Type Overview

Hyperion Defi, INC. (HYPD) has filed 38 8-K, 5 10-Q, 2 DEF 14A, 1 10-K/A, 1 10-K, 1 DEFA14A, 1 SC 13D/A, 1 SC 13G/A with the SEC between Aug 2024 to Mar 2026.

Filings by Year

2026 · 2025 · 2024

Recent Filings (50)

• HYPERION DEFI Files 8-K: Financials, Bylaw Changes, Reg FD Disclosure — 8-K · Mar 26, 2026
  HYPERION DEFI, INC. filed an 8-K on March 26, 2026, reporting on Items 2.02 (Results of Operations and Financial Condition), 5.03 (Amendments to Articles of Inc
• Hyperion Defi, Inc. Files 8-K Report — 8-K · Dec 10, 2025 Risk: medium
  On December 10, 2025, HYPERION DEFI, INC. (formerly EYENOVIA, INC.) filed an 8-K report. The filing indicates a change in the company's name and potentially oth
• Hyperion DeFi Enters Material Definitive Agreement — 8-K · Nov 17, 2025 Risk: medium
  On November 14, 2025, Hyperion DeFi, Inc. entered into a Material Definitive Agreement. The company, formerly known as Eyenovia, Inc., is incorporated in Delawa
• Hyperion DeFi Swings to Profit on Digital Asset Gains, HYPE Strategy Pays Off — 10-Q · Nov 14, 2025 Risk: high
  HYPERION DEFI, INC. (HYPD) reported a significant financial turnaround for the three months ended September 30, 2025, achieving a net income of $6,625,582, a st
• Hyperion Defi, Inc. (fka Eyenovia) Files 8-K — 8-K · Nov 13, 2025 Risk: low
  On November 13, 2025, Hyperion Defi, Inc. (formerly Eyenovia, Inc.) filed an 8-K report. The filing indicates a change in the company's name from Eyenovia, Inc.
• 8-K Filing — 8-K · Oct 31, 2025
• Hyperion Defi, Inc. Files 8-K: Board & Compensation Changes — 8-K · Oct 2, 2025 Risk: medium
  On September 30, 2025, HYPERION DEFI, INC. (formerly EYENOVIA, INC.) filed an 8-K report detailing changes in its board of directors and executive compensation.
• Hyperion DeFi Files 8-K: Officer/Director Changes & Financials — 8-K · Sep 29, 2025 Risk: medium
  On September 29, 2025, Hyperion DeFi, Inc. (formerly EyenovIA, Inc.) filed an 8-K report. The filing indicates changes in directors or officers, potential regul
• Hyperion DeFi Files 8-K for Material Agreement — 8-K · Sep 24, 2025 Risk: medium
  On September 24, 2025, Hyperion DeFi, Inc. (formerly Eyenovia, Inc.) filed an 8-K report. The filing indicates an entry into a material definitive agreement and
• Hyperion DeFi Faces Delisting Notice, Board Changes — 8-K · Sep 8, 2025 Risk: high
  Hyperion DeFi, Inc. (formerly EyenovIA, Inc.) filed an 8-K on September 8, 2025, reporting a change in its listing status. The company received a notice of deli
• Hyperion DeFi, Inc. Files 8-K Report — 8-K · Aug 21, 2025 Risk: medium
  On August 18, 2025, Hyperion DeFi, Inc. (formerly Eyenovia, Inc.) filed an 8-K report. The filing indicates a change in the company's name and potentially other
• Hyperion Defi, Inc. (fka Eyenovia) Files 8-K — 8-K · Aug 13, 2025 Risk: low
  On August 13, 2025, HYPERION DEFI, INC. filed an 8-K report. The filing indicates a change in the company's name from EYENOVIA, INC. to HYPERION DEFI, INC. on A
• Hyperion DeFi's Strategic Pivot: HYPE Tokens & Optejet Drive Mixed Q2 Results — 10-Q · Aug 13, 2025 Risk: high
  HYPERION DEFI, INC. (HYPD) reported a net loss of $12,174,452 for the six months ended June 30, 2025, a significant improvement from the $21,975,800 net loss in
• Hyperion DeFi Sets Virtual Annual Meeting for August 18 — DEF 14A · Jul 24, 2025 Risk: low
  HYPERION DEFI, INC. (HYPD) filed a Definitive Proxy Statement (DEF 14A) on July 24, 2025, for its Annual Meeting of Stockholders scheduled for August 18, 2025,
• Hyperion DeFi, Inc. Reports Board Changes and Fiscal Year Update — 8-K · Jul 2, 2025 Risk: medium
  On June 30, 2025, Hyperion DeFi, Inc. (formerly Eyenovia, Inc.) filed an 8-K report detailing several key events. The company announced changes in its board of
• EyEnovia Closes $25M Public Offering — 8-K · Jun 27, 2025 Risk: medium
  On June 25, 2025, EyEnovia, Inc. filed an 8-K report detailing the closing of its previously announced underwritten public offering. The company successfully ra
• Eyevia, Inc. Files 8-K: Material Agreement, Equity Sales, Officer Changes — 8-K · Jun 24, 2025 Risk: medium
  On June 17, 2025, Eyevia, Inc. entered into a material definitive agreement, likely related to financing or a significant business transaction. The company also
• EYENOVIA, INC. Files 8-K for Material Agreement — 8-K · Jun 5, 2025 Risk: medium
  On May 30, 2025, EYENOVIA, INC. entered into a material definitive agreement. The filing also includes financial statements and exhibits. The company is incorpo
• EYENOVIA, INC. Files 8-K on Financials — 8-K · May 19, 2025 Risk: low
  On May 19, 2025, EYENOVIA, INC. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as finan
• Eyenovia Files Q1 2025 10-Q, Details Warrant Valuations — 10-Q · May 19, 2025 Risk: medium
  Eyenovia, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information, including retained earnings and additional paid-in
• EYENOVIA, INC. Faces Delisting Concerns — 8-K · May 2, 2025 Risk: high
  On April 29, 2025, EYENOVIA, INC. filed an 8-K report indicating a notice of delisting or failure to satisfy a continued listing rule or standard. The company i
• EyenovIA, Inc. Files 2024 Annual Report Amendment — 10-K/A · Apr 30, 2025 Risk: medium
  EyenovIA, Inc. filed an amendment (10-K/A) to its annual report for the fiscal year ended December 31, 2024. The company, headquartered in New York, NY, is in t
• EYENOVIA, INC. Files 2024 10-K — 10-K · Apr 15, 2025 Risk: medium
  EYENOVIA, INC. filed its 2024 10-K on April 15, 2025, reporting its financial performance for the fiscal year ending December 31, 2024. The company, operating i
• EyEnovIA, Inc. Files 8-K Report — 8-K · Mar 20, 2025 Risk: low
  On March 18, 2025, EyEnovIA, Inc. filed an 8-K report detailing the results of operations and other events. The filing includes financial statements and exhibit
• EYENOVIA, INC. Files 8-K Report — 8-K · Feb 25, 2025 Risk: low
  On February 25, 2025, EYENOVIA, INC. filed an 8-K report. The filing indicates "Other Events" as the primary item of information. No specific details regarding
• EyEnovia, Inc. Files 8-K for Material Definitive Agreement — 8-K · Feb 24, 2025 Risk: medium
  On February 21, 2025, EyEnovia, Inc. entered into a material definitive agreement, creating a direct financial obligation. The company, incorporated in Delaware
• EYENOVIA, INC. Files 8-K Report — 8-K · Jan 31, 2025 Risk: low
  On January 31, 2025, EYENOVIA, INC. filed an 8-K report. The filing primarily concerns other events and financial statements/exhibits, with no specific material
• EYENOVIA, INC. Files 8-K Report — 8-K · Jan 28, 2025 Risk: low
  On January 28, 2025, EYENOVIA, INC. filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating potential updates or disclo
• EYENOVIA, INC. Files 8-K on Shareholder Vote Matters — 8-K · Jan 24, 2025 Risk: medium
  On January 21, 2025, EYENOVIA, INC. filed an 8-K report detailing a submission of matters to a vote of its security holders. The filing does not disclose specif
• EyEnovIA Files 8-K: Material Agreement, Equity Sales — 8-K · Jan 16, 2025 Risk: medium
  On January 16, 2025, EyEnovIA, Inc. entered into a Material Definitive Agreement. The company also reported on Unregistered Sales of Equity Securities and filed
• Eyenovia Files Definitive Proxy Statement — DEFA14A · Jan 15, 2025 Risk: low
  Eyenovia, Inc. filed a Definitive Proxy Statement (DEFA14A) on January 15, 2025. This filing includes information required for their proxy statement, which is u
• EyEnovia Closes $34.5M Public Offering — 8-K · Dec 30, 2024 Risk: medium
  On December 30, 2024, EyEnovia, Inc. announced the closing of its previously disclosed underwritten public offering. The company successfully raised approximate
• EyenovIA Files 2025 Proxy Statement — DEF 14A · Dec 23, 2024 Risk: low
  EyenovIA, Inc. filed its definitive proxy statement on December 23, 2024, for its 2025 annual meeting of stockholders scheduled for January 21, 2025. The filing
• EYENOVIA Faces Nasdaq Delisting Over Bid Price — 8-K · Dec 13, 2024 Risk: high
  On December 12, 2024, EYENOVIA, INC. filed an 8-K report indicating a potential delisting from the Nasdaq Capital Market. The company received a notice from Nas
• EyEnovia, Inc. Signs Material Definitive Agreement — 8-K · Dec 9, 2024 Risk: medium
  On December 5, 2024, EyEnovia, Inc. entered into a Material Definitive Agreement. The filing does not specify the other party or the nature of the agreement, bu
• Grant Amends Eyenovia Stake Filing — SC 13D/A · Dec 4, 2024 Risk: medium
  Stuart M. Grant filed an amendment (No. 6) to Schedule 13D on December 4, 2024, regarding Eyenovia, Inc. The filing pertains to common stock and indicates a cha
• EyEnovia, Inc. Files 8-K: Material Definitive Agreement — 8-K · Nov 26, 2024 Risk: medium
  On November 24, 2024, EyEnovia, Inc. entered into a Material Definitive Agreement. The filing also includes Regulation FD Disclosure and Financial Statements an
• Eyevia, Inc. Reports Material Agreement and Financial Obligations — 8-K · Nov 25, 2024 Risk: medium
  On November 22, 2024, Eyevia, Inc. entered into a material definitive agreement related to a direct financial obligation. The company also reported on the creat
• EyEnovIA, Inc. Files 8-K: Other Events — 8-K · Nov 20, 2024 Risk: medium
  On November 19, 2024, EyEnovIA, Inc. filed an 8-K report. The filing indicates an 'Other Events' category, suggesting a significant, non-routine event has occur
• EYENOVIA, INC. Files 8-K on Exit Costs and Other Events — 8-K · Nov 15, 2024 Risk: medium
  On November 15, 2024, EYENOVIA, INC. filed an 8-K report detailing cost associated with exit or disposal activities. The filing also includes other events and f
• SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• EYENOVIA, INC. Files 8-K on Financials — 8-K · Nov 12, 2024 Risk: low
  On November 12, 2024, EYENOVIA, INC. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as
• Eyenovia Q3 2024 Update: Financials and Operations — 10-Q · Nov 12, 2024 Risk: medium
  Eyenovia, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported total assets of $86.4 million and total liabilities of $45.6 millio
• EyEnovIA, Inc. Files 8-K for Material Definitive Agreement — 8-K · Sep 30, 2024 Risk: medium
  On September 26, 2024, EyEnovIA, Inc. entered into a Material Definitive Agreement, the details of which are not fully disclosed in this filing. The company, in
• EYENOVIA Receives Nasdaq Delisting Warning — 8-K · Sep 20, 2024 Risk: high
  On September 18, 2024, EYENOVIA, INC. filed an 8-K report indicating it received a notification from the Nasdaq Stock Market on September 17, 2024, that it is n
• EyEnovia Appoints New CMO, Closes $25M Financing — 8-K · Sep 3, 2024 Risk: medium
  On August 30, 2024, EyEnovia, Inc. filed an 8-K report detailing the departure of Director Michael J. Miller and the appointment of Dr. Arshad Khan as Chief Med
• EYENOVIA, INC. Files 8-K Report — 8-K · Aug 23, 2024 Risk: low
  On August 23, 2024, EYENOVIA, INC. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No specifi
• EyEnovia Files 8-K: Material Agreement, Financials — 8-K · Aug 22, 2024 Risk: medium
  On August 20, 2024, EyEnovia, Inc. entered into a Material Definitive Agreement. The filing also includes Regulation FD Disclosure and Financial Statements and
• Eyenovia Reports Q2 2024 Results, Licensing Deal — 10-Q · Aug 14, 2024 Risk: medium
  Eyenovia, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported total assets of $55.8 million and total liabilities of $45.6 million. Ke
• EYENOVIA, INC. Files 8-K on Financials — 8-K · Aug 13, 2024 Risk: low
  On August 12, 2024, EYENOVIA, INC. filed an 8-K report detailing its financial results and condition. The filing includes financial statements and exhibits, pro

Risk Profile

Risk Assessment: Of HYPD's 47 recent filings, 6 were flagged as high-risk, 28 as medium-risk, and 13 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.

Financial Highlights

Key financial metrics from Hyperion Defi, INC.'s most recent 10-Q filing (Nov 14, 2025):

• Revenue: $302,506
• Net Income: $6,625,582
• Cash Position: $8,223,180
• Total Assets: $82,789,907
• Total Debt: $12,034,875

Key Executives

• Stuart M. Grant
• Michael J. Miller
• Arshad Khan

Industry Context

The digital asset and decentralized finance (DeFi) industry is characterized by rapid innovation, high volatility, and an evolving regulatory landscape. Companies in this space often leverage new technologies to create novel financial products and services. Competition is fierce, with established financial institutions and numerous startups vying for market share. The industry is heavily influenced by technological advancements, investor sentiment, and regulatory pronouncements.

Top Tags

financials (8) · corporate-governance (7) · material-agreement (7) · filing (6) · name-change (5) · filing-update (5) · material-definitive-agreement (4) · corporate-action (4) · delisting (3) · listing-standards (3)

Key Numbers

• Net Income: $6,625,582 — for the three months ended September 30, 2025, a significant turnaround from a loss
• Net Loss: $7,887,853 — for the three months ended September 30, 2024
• Revenue: $302,506 — for the three months ended September 30, 2025, up from $1,625 in Q3 2024
• Realized gains - digital assets: $6,942,713 — for the three and nine months ended September 30, 2025
• Unrealized gains - digital assets: $6,440,804 — for the three and nine months ended September 30, 2025
• Impairment loss - digital intangible assets: $6,289,847 — for the three and nine months ended September 30, 2025
• Total Assets: $82,789,907 — as of September 30, 2025, a substantial increase from $3,667,759 at December 31, 2024
• HYPE - digital assets: $37,954,590 — on the balance sheet as of September 30, 2025
• Purchase of productive digital assets: $65,635,000 — for the nine months ended September 30, 2025
• Proceeds from sale of preferred stock and warrants: $50,000,000 — in private placement for the nine months ended September 30, 2025
• Commission File Number: 001-38365 — Identifies the company's filing with the SEC
• IRS Employer Identification No.: 47-1178401 — Company's tax identification number
• HYPE digital tokens: $45.50M — asset held as of June 30, 2025, representing a new strategic investment
• Cash and cash equivalents: $7.53M — as of June 30, 2025, up from $2.12M at December 31, 2024
• Net Cash Provided By Financing Activities: $58.82M — for the six months ended June 30, 2025, primarily from a private placement

Related Companies

EYEN

Frequently Asked Questions